The treatment is umeclidinium (a long-acting muscarinic atagonist and vilanterol, long-acting beta2-agonist) both can relax airway muscles and inside and out of the lungs.
The treatment combines umeclidinium, a long-acting muscarinic antagonist and vilanterol, a long-acting beta2-agonist. Both can relax airway muscles and improve airflow in and out of the lungs.